Aclarion, Inc. (NASDAQ:ACONW) Short Interest Update

Aclarion, Inc. (NASDAQ:ACONW) saw a large growth in short interest in the month of May. As of May 29th, there was short interest totaling 604 shares, a growth of 504.0% from the May 14th total of 100 shares. Based on an average daily trading volume, of 16,125 shares, the short-interest ratio is presently 0.0 days.

Aclarion Stock Performance

NASDAQ:ACONW opened at $0.03 on Wednesday. The stock’s fifty day moving average is $0.03 and its 200 day moving average is $0.04. Aclarion has a fifty-two week low of $0.02 and a fifty-two week high of $0.23.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.